For instance, Chen et al. confirmed the upregulation of YTHDF1 in cisplatin-resistant CRC cells, and silencing YTHDF1 alleviated cisplatin resistance via dampening GLS-mediated glutamine metabolism in CRC [209]. Here, YTHDF1 is linked to colorectal carcinoma.